IL13RA2 and neoplasm: To test the relevance of IL13RA2 in the metastatic setting, we performed intracardiac injection of MDA231BrM2-CTL or MDA231BrM2-ΔIL13RA2 cells in immunocompromised nude mice and tracked tumor development over four weeks (Fig. 3a).